Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have signed a consent form agreeing to take part in the study
- People who are over 18 years of age
- People who have previously had their prostate surgically removed and whose laboratory results confirmed prostate adenocarcinoma (a common type of prostate cancer), who may or may not have also had radiation therapy to the prostate area after surgery, and who now show signs of the cancer returning based on a specific blood protein level (PSA) that is above 0.2 but below 1 — and who, based on standard medical practice, would typically have a particular type of imaging scan (called a 68Ga-PSMA PET/CT scan) to check for signs of the cancer coming back
Who may not be able to join:
- People who have received hormone therapy (a treatment that lowers certain hormones to slow cancer growth) within the 6 months before joining the study
- People whose blood protein level (PSA) remained elevated above 0.1 ng/ml within 16 weeks after their prostate removal surgery, which may suggest the cancer was not fully removed rather than having returned later
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lorenzo Livi, Prof., Azienda Ospedaliero-Universitaria Careggi
Phone: +390557947264
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.